The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan Global Growth & Income Regulatory News (JGGI)

Share Price Information for JPMorgan Global Growth & Income (JGGI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 550.00
Bid: 548.00
Ask: 549.00
Change: 8.00 (1.48%)
Spread: 1.00 (0.182%)
Open: 544.00
High: 550.00
Low: 542.00
Prev. Close: 542.00
JGGI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing and WRAP Retail Offer

21 Feb 2024 07:00

RNS Number : 8264D
JPMorgan Global Growth & Income PLC
21 February 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

21 February 2024

JPMorgan Global Growth & Income plc

 

Result of Placing and WRAP Retail Offer

 

The Board of JPMorgan Global Growth & Income plc ("JGGI" or the "Company") is pleased to announce the successful completion of the placing (the "Placing") and the WRAP retail offer (the "WRAP Retail Offer") (the Placing and WRAP Retail Offer together, the "Fundraising"), raising gross proceeds of £34.5 million.

 

The WRAP Retail Offer has been materially oversubscribed, with orders received exceeding the ?8m limit and being subject to scale back in accordance with the terms of the Fundraising.

 

The Company will issue, subject to Admission (defined below), a total of 6,472,847 new ordinary shares of 5 pence each in the capital of the Company ("Shares") (the "New Shares") at a price of 533.75 pence per New Share (the "Issue Price"), representing a 0.60% premium to the cum-income NAV per Share as at 19 February 2024, being the last published NAV per Share prior to the close of the Fundraising, as announced earlier today.

 

5,198,847 New Shares will be issued pursuant to the Placing and 1,274,000 New Shares will be issued pursuant to the WRAP Retail Offer.

 

Admission and Settlement

 

Applications have been made to the Financial Conduct Authority for admission of the New Shares to the premium segment of the Official List and to the London Stock Exchange for admission to trading of the New Shares on its main market for listed securities ("Admission"). It is expected that Admission will become effective at or around 8.00 a.m. on 23 February 2024 and that dealings in the New Shares will commence at that time.

 

The New Shares will, when issued, be credited as fully paid and rank pari passu with the existing Shares, including the right to receive all future dividends and distributions declared, made or paid, with a record date on or after the date of Admission.

 

Immediately following Admission, the Company's issued share capital will consist of 438,981,016 Shares with voting rights. This figure may be used by shareholders in determining the denominator for the calculation by which they will establish if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Placing and the WRAP Retail Offer are conditional on Admission becoming effective. 

 

Tristan Hillgarth, Chairman of JGGI, commented:

 

"The level of demand for the Company's shares has been encouraging, in particular, the interest from a new large UK wealth manager alongside other new investors and existing shareholders. The Company has grown significantly in recent years via corporate actions, ongoing share issuance and most importantly, strong performance. This has enabled the Company to deliver scale, with net assets now well in excess of £2bn, and a material increase in the liquidity. The Company's tiered management fee structure ensures that shareholders benefit directly from this increased scale with an ongoing cost figure below 50bps, placing JGGI in a competitive position relative to comparable vehicles."

 

For further information please contact:

 

JPMorgan Global Growth & Income plc

Tristan Hillgarth

Contact via Company Secretary

 

JPMorgan Funds Limited

+44 (0) 20 7742 4000

Simon Crinage

Fin Bodman

 

JPMorgan Funds Limited (Company Secretary)

Divya Amin

+44 (0) 20 7742 4000

 

Winterflood Securities (Broker to the Company)

Neil Langford

Haris Khawaja

 

+44(0) 20 3100 0000

Winterflood Retail Access Platform

Andrew Stancliffe

Phoebe Pankhurst

 

WRAP@winterflood.com

+44(0) 20 3100 0000

 

 

LEI: 5493007C3I0O5PJKR078

 

 

IMPORTANT NOTICE

 

The content of this announcement has been prepared by, and is the sole responsibility of, JPMorgan Global Growth & Income plc.

 

The information contained in this announcement is given at the date of its publication and is subject to updating, revision and amendment from time to time. Neither the content of the Company's website nor any website accessible by hyperlinks to the Company's website is incorporated in, or forms part of, this announcement.

 

Winterflood, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Winterflood or advice to any other person in relation to the matters contained herein.

 

The shares of the Company have not been, nor will they be, registered under the US Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States or under the applicable securities laws of Australia, Canada, Japan, New Zealand or South Africa. Further, the Company has not been and will not be registered under the US Investment Company Act of 1940, as amended. Subject to certain exceptions, the shares of the Company may not be offered or sold in any member state of the EU, the United States of America, Canada, Australia, Japan, New Zealand or South Africa or to or for the account or benefit of any national, resident or citizen of any member state of the EU, Canada, Australia, Japan, New Zealand or South Africa or any person located in the United States. The Placing and the distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

 

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, strategy, plans, proposed acquisitions and objectives are forward-looking statements.

 

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These forward-looking statements speak only as at the date of this announcement. The Company, the Investment Manager and Winterflood expressly disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Prospectus Regulation Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIDBLFLZLLZBBB
Date   Source Headline
3rd May 20243:01 pmRNSIssue of Equity
3rd May 202412:23 pmRNSIssue of Equity
3rd May 202410:57 amRNSNet Asset Value(s)
3rd May 20247:00 amRNSDividend Declaration
2nd May 20243:15 pmRNSIssue of Equity
2nd May 20243:11 pmRNSIssue of Equity
2nd May 20241:20 pmRNSIssue of Equity
2nd May 20241:15 pmRNSIssue of Equity
2nd May 202411:19 amRNSNet Asset Value(s)
1st May 20244:50 pmRNSIssue of Equity
1st May 20242:57 pmRNSIssue of Equity
1st May 202412:28 pmRNSTotal Voting Rights
1st May 202411:23 amRNSNet Asset Value(s)
30th Apr 20245:18 pmRNSIssue of Equity
30th Apr 20244:31 pmRNSIssue of Equity - Replacement
30th Apr 20243:51 pmRNSIssue of Equity
30th Apr 20242:44 pmRNSIssue of Equity
30th Apr 202412:17 pmRNSIssue of Equity
30th Apr 202411:06 amRNSNet Asset Value(s)
29th Apr 20242:45 pmRNSIssue of Equity
29th Apr 202412:01 pmRNSGearing Announcement
29th Apr 202411:04 amRNSNet Asset Value(s)
26th Apr 20244:39 pmRNSIssue of Equity
26th Apr 20244:34 pmRNSIssue of Equity
26th Apr 20244:29 pmRNSIssue of Equity
26th Apr 202410:47 amRNSNet Asset Value(s)
25th Apr 20244:49 pmRNSIssue of Equity
25th Apr 202410:09 amRNSNet Asset Value(s)
24th Apr 20243:54 pmRNSIssue of Equity
24th Apr 20243:48 pmRNSIssue of Equity
24th Apr 20241:22 pmRNSIssue of Equity
24th Apr 202412:48 pmRNSIssue of Equity
24th Apr 202410:19 amRNSNet Asset Value(s)
23rd Apr 20243:58 pmRNSIssue of Equity
23rd Apr 20243:54 pmRNSIssue of Equity
23rd Apr 20243:51 pmRNSIssue of Equity
23rd Apr 20243:48 pmRNSIssue of Equity
23rd Apr 202410:31 amRNSNet Asset Value(s)
22nd Apr 20241:56 pmRNSIssue of Equity
22nd Apr 20241:45 pmRNSIssue of Equity
22nd Apr 202412:09 pmRNSIssue of Equity
22nd Apr 202412:03 pmRNSIssue of Equity
22nd Apr 202411:59 amRNSIssue of Equity
22nd Apr 202411:20 amRNSGearing announcement
22nd Apr 202410:48 amRNSNet Asset Value(s)
19th Apr 20244:51 pmRNSIssue of Equity
19th Apr 202410:26 amRNSNet Asset Value(s)
18th Apr 20243:18 pmRNSIssue of Equity
18th Apr 20243:14 pmRNSIssue of Equity
18th Apr 20243:10 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.